Skip to content

Obsessive-Compulsive Disorder (OCD): Psychological Treatment

Comparing the Efficacy of Meta-Cognitive and Cognitive-Behavioral Therapy on Obsession and Compulsion symptoms of Patients with Obsessive-Compulsive Disorder (OCD)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015012220728N1
Enrollment
22
Registered
2015-05-16
Start date
2015-03-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-compulsive disorder. The essential feature is recurrent obsessional thoughts or compulsive acts. Obsessional thoughts are ideas, images, or impulses that enter the patient's mind again and again in a stereotyped form. They are almost invariably distressing and the patient oft

Interventions

Intervention 1: CBT for OCD, protocol D.Clarck (2004) there will be 10 sessions and each session is 1 hour. Intervention 2: MCT for OCD, Protocol A.Wells (2009) there will be 10 sessions an
Treatment - Other
CBT for OCD, protocol D.Clarck (2004) there will be 10 sessions and each session is 1 hour.
MCT for OCD, Protocol A.Wells (2009) there will be 10 sessions and each session is 1 hour.

Sponsors

Behavioral Sciences Research Center of Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Having a diagnosis of obsessive-compulsive disorder, based on semi-structured interview SCID-I; Having aged between 20 to 50 years old; The consent of subjects, and completing the ethical consent form to participate in a research study. Exclusion Criteria: Having a concurrent diagnosis of psychotic disorders, major depressive disorder, bipolar disorder, neurological disorders that cause similar symptoms as OCD, substance abuse, alcohol and drugs abuse, Sever personality disorders; The need for psychiatric emergencies; Get medication and other drugs in relation to other psychological problems simultaneously with the present study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of obsessive thoughts. Timepoint: Before the intervention, in the middle of intervention, after intervetion (three months after intervention), a month after intervention. Method of measurement: Yale Brown scale (Y-BOCS).;Compulsive severity. Timepoint: Before the intervention, in the middle of intervention, after intervetion (three months after intervention), a month after intervention. Method of measurement: Y-BOCS symptom severity checklist.;Cognition. Timepoint: Before the intervention, in the middle of intervention, after intervetion (three months after intervention), a month after intervention. Method of measurement: OBQ.;Metacognition. Timepoint: Before the intervention, in the middle of intervention, after intervetion (three months after intervention), a month after intervention. Method of measurement: MCQ.

Secondary

MeasureTime frame
Anxiety. Timepoint: Before the intervention, in the middle of intervention, after intervetion (three months after intervention), a month after intervention. Method of measurement: Anxiety- BAI.;Depression. Timepoint: Before the intervention, in the middle of intervention, after intervetion (three months after intervention), a month after intervention. Method of measurement: depression- BDI.;Emotional regulation. Timepoint: Before the intervention, in the middle of intervention, after intervetion (three months after intervention), a month after intervention. Method of measurement: emotional regulation- DERS.;Quality of life. Timepoint: Before the intervention, in the middle of intervention, after intervetion (three months after intervention), a month after intervention. Method of measurement: WHOQOL.;Function. Timepoint: Before the intervention, in the middle of intervention, after intervetion (three months after intervention), a month after intervention. Method of measurement: WHO DAS 2.0.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactsepideh rajezi

Behavioral Sciences Research Center of Shahid Beheshti University of Medical Sciences

Sepideh.rajezi@gmail.coms.rajezi@sbmu.ac.ir+98 21 7755 3074

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026